| Product Code: ETC7551779 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India Prader-Willi Syndrome drug market import shipments experienced a negative Compound Annual Growth Rate (CAGR) from 2020-2024. However, there was a notable positive growth rate between 2023 and 2024. Overall, the market showed signs of stabilization after a period of decline, indicating a potential turnaround in the near future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Prader-Willi Syndrome Drug Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Prader-Willi Syndrome Drug Market Revenues & Volume, 2021 & 2031F |
3.3 India Prader-Willi Syndrome Drug Market - Industry Life Cycle |
3.4 India Prader-Willi Syndrome Drug Market - Porter's Five Forces |
3.5 India Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Branded Drugs, 2021 & 2031F |
3.7 India Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 India Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 India Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.10 India Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 India Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Prader-Willi Syndrome Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of Prader-Willi Syndrome in India |
4.2.2 Growing healthcare infrastructure and facilities to support PWS patients |
4.2.3 Rising research and development activities for PWS drugs in the Indian market |
4.3 Market Restraints |
4.3.1 Limited reimbursement options for PWS drugs in India |
4.3.2 High costs associated with PWS drug development and treatment |
4.3.3 Regulatory hurdles and approval processes for new drugs in the Indian market |
5 India Prader-Willi Syndrome Drug Market Trends |
6 India Prader-Willi Syndrome Drug Market, By Types |
6.1 India Prader-Willi Syndrome Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Paternal Deletion, 2021- 2031F |
6.1.4 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Maternal Uniparental Disomy (UPD), 2021- 2031F |
6.1.5 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Imprinting Defect, 2021- 2031F |
6.2 India Prader-Willi Syndrome Drug Market, By Branded Drugs |
6.2.1 Overview and Analysis |
6.2.2 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Genotropin, 2021- 2031F |
6.2.3 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Omnitrope Norditropin, 2021- 2031F |
6.2.4 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Prader-Willi Syndrome Drug Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.3.3 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.3.4 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.4 India Prader-Willi Syndrome Drug Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.4.3 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Physical therapy, 2021- 2031F |
6.4.4 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Behavioral Therapy, 2021- 2031F |
6.5 India Prader-Willi Syndrome Drug Market, By Treatment |
6.5.1 Overview and Analysis |
6.5.2 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Medications, 2021- 2031F |
6.5.3 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Dietary treatment, 2021- 2031F |
6.5.4 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Human Growth Hormone replacement, 2021- 2031F |
6.5.5 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Sex hormone Replacement, 2021- 2031F |
6.6 India Prader-Willi Syndrome Drug Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.6.4 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Intranasal, 2021- 2031F |
6.6.5 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.7 India Prader-Willi Syndrome Drug Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Direct, 2021- 2031F |
6.7.3 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.7.4 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.8 India Prader-Willi Syndrome Drug Market, By End-Users |
6.8.1 Overview and Analysis |
6.8.2 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.8.3 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.8.4 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 India Prader-Willi Syndrome Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 India Prader-Willi Syndrome Drug Market Import-Export Trade Statistics |
7.1 India Prader-Willi Syndrome Drug Market Export to Major Countries |
7.2 India Prader-Willi Syndrome Drug Market Imports from Major Countries |
8 India Prader-Willi Syndrome Drug Market Key Performance Indicators |
8.1 Number of clinical trials conducted for PWS drugs in India |
8.2 Adoption rate of new PWS treatment options in the market |
8.3 Number of healthcare facilities specialized in PWS care in India |
9 India Prader-Willi Syndrome Drug Market - Opportunity Assessment |
9.1 India Prader-Willi Syndrome Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Prader-Willi Syndrome Drug Market Opportunity Assessment, By Branded Drugs, 2021 & 2031F |
9.3 India Prader-Willi Syndrome Drug Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 India Prader-Willi Syndrome Drug Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 India Prader-Willi Syndrome Drug Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.6 India Prader-Willi Syndrome Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 India Prader-Willi Syndrome Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.7 India Prader-Willi Syndrome Drug Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 India Prader-Willi Syndrome Drug Market - Competitive Landscape |
10.1 India Prader-Willi Syndrome Drug Market Revenue Share, By Companies, 2024 |
10.2 India Prader-Willi Syndrome Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here